Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.


TSXV:NGEN - Post by User

Comment by RHertigon Jan 29, 2024 6:14pm
256 Views
Post# 35851533

RE:Big boys have stopped buying. What it means.

RE:Big boys have stopped buying. What it means.
stargazer1 wrote:
rdge44 thanks for the kind words. When it comes to MS, I think that there may be hope. Last week literally millions of shares were bought in just a few days. Buying continued through the first half of Thursdays trading, and then stopped. Since then, volume has been light, and the stock has been dropping. I would guess that the people that were doing the buying have bought all that they wanted. But the point is that MILLIONS of shares were bought and that wouldn't have taken place if something major hadn't happened. Like outstanding results already in the patients that have started the drug trials.
 
All that buying for day after day must mean that at least several, or more, people in the know must have seen something that really impressed them. If it was just one person that was behind the buying it wouldn't have gone on for days.
 
It may be that it was people in management that were startled with something they saw and jumped in before the results were announced.
 
Management has previously been buying shares, but not in such big amounts, and not for day after day.
 
NerveGen's drug lets the body repair damaged, and even severed neurons. This would include neurons that have been damaged from multiple sclerosis. However, multiple sclerosis is caused by a person's immune system
attacking the myelin sheath of the brain's neurons.
 
NerveGen's drug may not stop that, but it could be used along with drugs such as Ibudilast that counteract the immune response.
 
But my point is that last week's trading could indicate that there has been an indication that the people that have been dosed with our drug have had some good indication that it is (very) effective. Even if this isn't the reason for the stock's rise. Over the longer term, I think that the drug will prove its effectiveness.
 
Good luck to you and your family. 
I have a big chunk of shares. I plan to hold thru all the trials. I can answer the big jump mystery. There was a big pump on Reddit. 

<< Previous
Bullboard Posts
Next >>